N Onetto

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

Edward L. Trimble, Jascha Adams, D. Vena et al. · Journal of Clinical Oncology · 1993 · 273 citations

Medicine, Oncology, Pharmacology +13

Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial.

Jeffrey S. Abrams, D. Vena, Janet H. Baltz et al. · Journal of Clinical Oncology · 1995 · 120 citations

Medicine, Oncology, Pharmacology +16

Successful re-treatment with taxol after major hypersensitivity reactions.

David M. Peereboom, Ross C. Donehower, E. Eisenhauer et al. · Journal of Clinical Oncology · 1993 · 113 citations

Medicine, Pharmacology, Pharmacotherapy +14

Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating Factor

Andrew D. Seidman, Russell K. Portenoy, T. J. Yao et al. · JNCI Journal of the National Cancer Institute · 1995 · 98 citations

Medicine, Oncology, Pharmacology +13

Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor.

T Hoang, Beth Levy, N Onetto et al. · The Journal of Experimental Medicine · 1989 · 75 citations · Full text

Life Sciences, Hematology, Immunology +9